MedTrace Logo

Platelet Rich Plasma in Knee Osteoarthritis

NCT05080075 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 33

Last updated 2024-05-07

No results posted yet for this study

Summary

In this study, the investigators will be performing intra-articular platelet rich plasma (PRP) injections for patients experiencing pain related to osteoarthritis of the knee. The investigators will be following clinical outcomes, and how they relate to concentrations of the PRP samples as well as following opioid and emergency room utilization pre and post-injection.

Conditions

Interventions

BIOLOGICAL

Platelet Rich Plasma Injection

Research participants own blood will be used to prepare the platelet rich plasma injectate, which will be injected into the affected knee using ultrasound guidance.

Sponsors & Collaborators

  • University of Toledo Health Science Campus

    lead OTHER

Principal Investigators

  • Christian Wuescher, MD · University of Toledo

  • Ashley Schneider, MD · University of Toledo

  • Leah Wuescher, PhD · University of Toledo

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-12-02
Primary Completion
2023-11-06
Completion
2023-11-06
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05080075 on ClinicalTrials.gov